The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Semi-Solid Dosage Contract Manufacturing Market In 2026 And 2030?
The semi-solid dosage contract manufacturing market has experienced rapid expansion recently. Projections indicate it will increase from $17.97 billion in 2025 to $19.89 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.7%. Historically, this growth can be ascribed to several factors, including the increasing complexity of pharmaceutical pipelines, mounting cost pressures associated with in-house manufacturing, the wider adoption of topical and transdermal drug applications, an escalating need for contract manufacturing services, and the presence of specialized cmo capabilities.
The semi-solid dosage contract manufacturing market is projected to experience substantial growth in the upcoming period, set to reach $29.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. This expansion is driven by factors such as the rising demand for personalized topical treatments, increased investment in advanced formulation technologies, the growth of cosmeceutical outsourcing, a heightened focus on sustainable excipient use, and stricter regulatory oversight on manufacturing quality. Key trends expected during this period involve a surge in the outsourcing of semi-solid drug production, increasing requirements for specialized dermatological products, wider implementation of adaptable manufacturing lines, the development of bio-based and natural formulations, and a stronger emphasis on production compliant with regulations.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25899&type=smp
What Key Factors Are Affecting The Semi-Solid Dosage Contract Manufacturing Market Demand?
The substantial prevalence of skin diseases is projected to drive the growth of the semi-solid dosage contract manufacturing market going forward. Skin diseases refer to conditions that affect the skin’s appearance or function, often leading to symptoms such as irritation, inflammation, or unusual skin growths. These conditions are increasing due to rising environmental pollution, which weakens the skin’s defense mechanisms, resulting in heightened sensitivity, allergic reactions, and persistent skin problems. Contract manufacturing of semi-solid dosage forms supports the prevention of skin diseases by delivering high-quality, reliably formulated topical treatments that effectively maintain and improve skin health. For instance, in February 2023, according to Cancer Research UK, a UK-based cancer research organization, the average yearly incidence of melanoma skin cancer in the UK is anticipated to grow from around 20,800 cases in 2023–2025 to roughly 26,500 cases by 2038–2040. Consequently, the widespread occurrence of skin diseases is propelling the expansion of the semi-solid dosage contract manufacturing market.
What Are The Different Segment Types In The Semi-Solid Dosage Contract Manufacturing Market Segment Breakdown?
The semi-solid dosage contract manufacturing market covered in this report is segmented –
1) By Type: Topical, Transdermal, Oral
2) By Material Type: Synthetic, Natural, Bio-Based
3) By Company Size: Large Size Companies, Medium And Small Size Companies
4) By Therapeutic Application: Dermatology, Pain Management, Hormonal Therapy, Wound Care, Ophthalmic Disorders, Other Therapeutic Applications
5) By End Use: Pharmaceutical Companies, Cosmeceutical Companies, Other End Uses
Subsegments:
1) By Topical: Creams, Ointments, Gels, Lotions, Pastes, Foams
2) By Transdermal: Transdermal Gels, Transdermal Creams, Transdermal Sprays, Transdermal Emulsions, Medicated Patches
3) By Oral: Oral Gels, Oral Pastes, Oral Suspensions, Oral Emulsions, Oral Jellies
What Trends Are Influencing Changes In The Semi-Solid Dosage Contract Manufacturing Market?
Companies operating in the semi-solid dosage contract manufacturing market are concentrating on strategic investments to penetrate new markets and stimulate innovation. Strategic investments represent long-term financial decisions aimed at supporting a company’s core objectives, future growth, or its competitive standing. For illustration, in March 2025, LGM Pharma, a US-based provider of semi-solid dosage contract manufacturing services, announced an investment exceeding $6 million dedicated to enlarging its manufacturing facility in Rosenberg, Texas. This investment seeks to boost the production capacity for liquid, suspension, semi-solid, and suppository drug formulations, thereby meeting the escalating demand for domestic pharmaceutical manufacturing. It aligns with LGM Pharma’s ongoing expansion efforts in prescription drug development, encompassing 505(b)(2) and ANDA programs. The enhancements at the Rosenberg site are expected to facilitate higher output while ensuring full compliance with FDA requirements and current good manufacturing practices, with the facility continuing operations without interruption during the expansion.
Who Are The Well-Known Companies In The Semi-Solid Dosage Contract Manufacturing Market?
Major companies operating in the semi-solid dosage contract manufacturing market are The Lubrizol Corporation, Recipharm AB, Piramal Pharma Solutions Inc., Cambrex Corporation, ANI Pharmaceuticals, Aurigene Pharmaceutical Services Limited, DPT Laboratories Ltd., Douglas Pharmaceuticals Ltd., Mission Pharmacal Co., Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Fermion Oy, Ferndale Pharma Group, Sterling Pharmaceutical Services LLC, Aphena Pharma Solutions Inc., Eubioco LLC, Madras Pharmaceuticals, Quality CDMO, Axxelent Pharma Science, Tergus Pharma, MedPharm Ltd., Alcami Corporation
Get The Full Semi-Solid Dosage Contract Manufacturing Market Report:
Which Region Dominates The Semi-Solid Dosage Contract Manufacturing Market By Market Share?
North America was the largest region in the semi-solid dosage contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the semi-solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Semi-Solid Dosage Contract Manufacturing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Semi-Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company
Oral Solid Dosage Pharmaceutical Formulation Market Report 2026
Fill Finish Pharmaceutical Contract Manufacturing Market Report
Pharmaceutical Continuous Manufacturing Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model